Isofol Medical
ISOFOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009581051
- LEI:
- 549300MCXYAHG7VBHX75
- Country:
- Sweden
- Address:
- C/O Biotech Center, Arvid Wallgrens, 413 46 Göteborg
- Website:
- https://isofolmedical.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Isofol Medical AB (publ), founded in 2008, is a biotech company that is developing a new drug candidate for the treatment of advanced colorectal cancer. Colorectal cancer (CRC) is the third most common form of cancer worldwide and there is a very high need for more effective drugs to treat this disease. Vision: “Isofol will help extend life and improve the quality of life for cancer patients” Arfolitixorin is being developed and commercialized through a global licensing agreement with Merck & Cie in Germany. The licensing agreement also grants Isofol access to the unique patented manufacturing process for arfolitixorin.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Nytt antal aktier och röster i Isofol
|
Swedish | 60.6 KB | |
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Isofol
|
English | 61.3 KB | |
| 2025-07-04 18:00 |
Regulatory News Service
Isofol's rights issue fully subscribed – exercises overallotment for Japanese p…
|
English | 128.5 KB | |
| 2025-07-04 18:00 |
Share Issue/Capital Change
Isofols företrädesemission övertecknad – utnyttjar övertilldelning till japansk…
|
Swedish | 127.3 KB | |
| 2025-06-17 08:40 |
Prospectus
Isofol offentliggör prospekt i samband med bolagets företrädesemission
|
Swedish | 98.7 KB | |
| 2025-06-17 08:40 |
Prospectus
Isofol publishes prospectus in connection with the company’s rights issue
|
English | 119.6 KB | |
| 2025-06-11 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on…
|
English | 94.5 KB | |
| 2025-06-11 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från extra bolagsstämma i Isofol Medical AB (publ) den 11 juni 2025
|
Swedish | 74.5 KB | |
| 2025-06-05 08:30 |
Share Issue/Capital Change
Isofol offentliggör slutliga villkor i företrädesemission samt för en potentiel…
|
Swedish | 142.5 KB | |
| 2025-06-05 08:30 |
Share Issue/Capital Change
Isofol announces final terms of the rights issue and the potential overallotmen…
|
English | 167.4 KB | |
| 2025-05-21 16:40 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from annual general meeting in Isofol Medical AB (publ) held on May 21…
|
English | 95.5 KB | |
| 2025-05-21 16:40 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma i Isofol Medical AB (publ) den 21 maj 2025
|
Swedish | 90.1 KB | |
| 2025-05-21 08:00 |
Interim Report
|
Swedish | 725.3 KB | |
| 2025-05-21 08:00 |
Regulatory News Service
|
English | 722.9 KB | |
| 2025-05-12 08:45 |
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma den 11 juni 2025 i Isofol Medical AB (publ)
|
Swedish | 135.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2020-06-05 | Gustaf Albèrt | Other | Other | 1,542 | 5,397.00 SEK |
| 2020-06-02 | HealthCom GmbH | Other | Buy | 133,336 | 466,676.00 SEK |
| 2020-06-01 | Gustaf Albèrt | Other | Other | 10,664 | 37,324.00 SEK |
| 2020-06-01 | Sven Eriksson | Other | Other | 9,332 | 32,662.00 SEK |
| 2020-06-01 | Sven Eriksson | Other | Other | 9,223 | 32,280.50 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |